DSM-firmenich prevails in patent suit

THE WHAT? DSM-firmenich has announced that it has won a patent infringement case against Mara Renewables and its UK subsidiary, Algal Omega 3 (AO3). The UK High Court of Justice found that the defendants’ unauthorized use of DSM-firmenich’s processing technology infringed a valid patent covering algal-based docasahexaenoic acid (DHA).

THE DETAILS The intellectual property at the heart of this litigation protects DSM-firmenich’s advances in biotechnology and downstream process engineering, which enable the development and production of high-purity algal DHA oils with superior sensory profiles.
After a trial last fall, it has now been established that Mara/AO3 were infringing a dsm-firmenich patent during a period beginning in 2017.

THE WHY? Francois Scheffler, Executive Vice President of Global Marketing and Business Development of DSM-firmenich’s Health, Nutrition, and Care Business Unit, comments, “This result confirms our contentions that Mara and AO3 have been unlawfully using DSM-firmenich’s legitimate IP rights. We now intend to pursue a full recovery for the damages we have suffered on account of the infringement, and remain even more committed to further defending and enforcing our IP rights in the UK and elsewhere.”

The post DSM-firmenich prevails in patent suit appeared first on Global Cosmetics News.